Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Hidden Markov Models (HMMs) for Medical Applications
*Corresponding Author: Ke Zhang, Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg 69120, Germany, Email: ke.zhang@uni-heidelberg.deReceived Date: Sep 04, 2024 / Published Date: Oct 04, 2024
Citation: Gang Q, Zhou F, Zhang K (2024) Hidden Markov Models (HMMs) for Medical Applications. J Oncol Res Treat S1:001.
Copyright: © 2024 Zhang K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits restricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Hidden Markov Models (HMMs) have emerged as a fundamental statistical tool in medical research, offering robust capabilities for modeling temporal processes characterized by unobservable hidden states. This review discusses the evolution and application of various HMM types in the medical field, including discrete, continuous, Hidden Semi-Markov, Hierarchical, and Coupled HMMs. These models have been used to address challenges across diverse medical contexts, from diagnosing disease states to tracking the progression of chronic conditions such as Alzheimer’s and cardiovascular diseases. We outline the structured methodological framework necessary to build HMMs for medical applications, emphasizing the importance of data pre-processing, feature extraction, parameter estimation, and model validation. The utility of HMMs in modeling continuous physiological signals, such as EEG, ECG and MRI data is highlighted, demonstrating their relevance in personalized medicine and disease progression modeling. Evaluation metrics, including accuracy, sensitivity and specificity are discussed in relation to the model’s clinical applicability and predictive power. The review concludes with a discussion of emerging trends in the use of HMMs, particularly their growing importance in genomics, pharmacometrics and infection transmission modeling. This comprehensive analysis underscores the versatility of HMMs in addressing complex temporal medical phenomena and their potential to enhance diagnostic, prognostic and therapeutic strategies in the future of healthcare.
